CVS / Caremark Corporation is among the world’s largest Drug Retail sector businesses in the world. CVS / Caremark Corporation’s employees generate $1.448B in profits on $47.019B of revenue. Global output in the Drug Retail business will likely rise substantially over the next 10 years. Long-term economic growth may lift all boats, but CVS / Caremark Corporation is determined to remain a market leader. Sectoral leadership in the Drug Retail segment takes dedication and consistency, but management seeks out-sized growth.
CVS / Caremark Corporation’s ticker symbol CVS has recently been trading near $36.57 a share. The CVS / Caremark Corporation corporate headquarters in Woonsocket, RI predicts Drug Retail profits will satisfy shareholders in search of risk-appropriate returns.
The significance of market volume is sometimes ignored, but with a total market capitalization of $57.200B ensures sufficient liquidity. With a beta of 1.22, the company is more volatile than the market as a whole. When the average equity moves higher, CVS / Caremark Corporation moves more aggressively.
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment